Quality concerns in antipsychotic prescribing for youth: A review of treatment guidelines

Academic Pediatrics

Volumn 14, Issue 5 SUPPL., 2014, Pages

  Kealey, Edith ^a   Scholle, Sarah Hudson ^b   Byron, Sepheen C ^b   Hoagwood, Kimberly ^c   Leckman Westin, Emily ^a,d   Kelleher, Kelly ^e   Finnerty, Molly ^a,c  

^a NEW YORK STATE OFFICE OF MENTAL HEALTH   (United States)

^b NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

adolescents; antipsychotic agents; children; practice guidelines as topic; quality indicators

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADVISORY COMMITTEE; AGGRESSION; ARTICLE; BIPOLAR DISORDER; CHILD PSYCHIATRY; CONSENSUS; FOLLOW UP; FOSTER CARE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; INTERVENTION STUDY; LIPID ANALYSIS; OPPOSITIONAL DEFIANT DISORDER; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; SCHIZOPHRENIA; SCREENING; SOCIAL PSYCHOLOGY; TREATMENT INDICATION; ADOLESCENT; CHILD; INFANT; PRESCHOOL CHILD; PSYCHOTIC DISORDERS; UNITED STATES;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; PRACTICE GUIDELINES AS TOPIC; PSYCHOTIC DISORDERS; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 84906849976     PISSN: 18762859     EISSN: 18762867     Source Type: Journal    
DOI: 10.1016/j.acap.2014.05.009     Document Type: Note

References (34)

1. J.C. Seida, J.R. Schouten, and K. Boylan et al. Antipsychotics for children and young adults: a comparative effectiveness review Pediatrics 129 2012 e771 e784
2. S. Crystal, M. Olfson, and C. Huang et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges Health Aff (Millwood) 28 2009 w770 w781
3. R.B. Penfold, C. Stewart, and E.M. Hunkeler et al. Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep 15 2013 426
4. S.J. Adams, S. Xu, and F. Dong Differences in Prescribing Patterns of Psychotropic Medication for Children and Adolescents Between Rural and Urban Prescribers 2009 WICHE Center for Rural Mental Health Research Boulder, Colo
5. Medicaid Medical Directors Learning Network Rutgers Center for Education and Research on Mental Health Therapeutics Antipsychotic Medication Use in Medicaid Children and Adolescents. Report and Resource Guide From a 16-State Study 2010 MMDLN/Rutgers CERT New Brunswick, NJ
6. M. Maglione, A.R. Maher, and J. Hu et al. Off-Label Use of Atypical Antipsychotics: An Update 2011 Agency for Healthcare Research and Quality Rockville, Md
7. C.U. Correll, P. Manu, and V. Olshanskiy et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents JAMA 302 2009 1765 1773
8. J.C. Seida, J.R. Schouten, and S.S. Mousavi et al. First- and Second-Generation Antipsychotics for Children and Young Adults 2012 Agency for Healthcare Research and Quality Rockville, Md
9. P.S. Jensen, J. Buitelaar, and G.J. Pandina et al. Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials Eur Child Adolesc Psychiatry 16 2007 104 120
10. Administration on Children Youth, and Families ACYF-CB-IM-12-03 Information Memorandum on Promoting the Safe, Appropriate, and Effective Use of Psychotropic Medication for Children in Foster Care 2012 US Dept of Health and Human Services Washington, DC
11. L. Stambaugh, L.K. Leslie, and H. Ringeisen et al. Psychotropic Medication Use by Children in Child Welfare 2012 Office of Planning, Research, and Evaluation; Administration for Children and Families; US Dept of Health and Human Services Washington, DC
12. B.T. Zima, J.M. Murphy, and S.H. Scholle et al. National quality measures for child mental health care: background, progress, and next steps Pediatrics 131 suppl 1 2013 S38 S49
13. S.C. Byron, W. Gardner, L. Kleinman, and R. Mangione-Smith et al. Developing measures for pediatric quality: methods and experiences of the pediatric quality measures program Acad Pediatr 14 2014 S27 S32
14. Health Services Advisory Group Inc A Blueprint for the CMS Measures Management System 2012 Health Services Advisory Group Inc Phoeniz, Ariz
15. Rutgers University Institute for Health, Health Care Policy, and Aging. Accelerating utilization of comparative effectiveness findings in Medicaid mental health: Medicaid Network for Evidence-based Treatment (MEDNET). Available at: http://www.academyhealth.org/files/FileDownloads/MEDNET.pdf. Accessed April 3, 2014.
16. Center for Health Care Strategies Inc. Improving the use of psychotropic medication among children and youth in foster care: a quality improvement collaborative. Available at: http://www.chcs.org/info-url-nocat3961/info-url- nocat-show.htm?doc-id=1261326. Accessed April 3, 2014.
17. J. McClellan, R. Kowatch, and R.L. Findling Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder J Am Acad Child Adolesc Psychiatry 46 2007 107 125
18. H. Steiner, and L. Remsing Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder J Am Acad Child Adolesc Psychiatry 46 2007 126 141
19. T. Pringsheim, C. Panagiotopoulos, J. Davidson, and J. Ho Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth J Can Acad Child Adolesc Psychiatry 20 2011 218 233
20. N. Scotto Rosato, C.U. Correll, and E. Pappadopulos et al. Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management Pediatrics 129 2012 e1577 e1586
21. M.M. Gleason, H.L. Egger, and G.J. Emslie et al. Psychopharmacological treatment for very young children: contexts and guidelines J Am Acad Child Adolesc Psychiatry 46 2007 1532 1572
22. E. Pappadopulos, J.C. Macintyre Ii, and M.L. Crismon et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II J Am Acad Child Adolesc Psychiatry 42 2003 145 161
23. American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of atypical antipsychotic medications in children and adolescents. Available at: http://www.aacap.org/App-Themes/AACAP/docs/practice-parameters/ Atypical-Antipsychotic-Medications-Web.pdf. Accessed July 12, 2012.
24. American Academy of Child and Adolescent Psychiatry Practice parameter on the use of psychotropic medication in children and adolescents J Am Acad Child Adolesc Psychiatry 48 2009 961 973
25. American Academy of Child and Adolescent Psychiatry Practice parameter for the assessment and treatment of children and adolescents with schizophrenia J Am Acad Child Adolesc Psychiatry 40 7 suppl 2001 4S 23S
26. Texas Department of Family and Protective Services and University of Texas at Austin College of Pharmacy. Psychotropic medication utilization parameters for foster children. Available at: http://www.dfps.state.tx.us/ documents/Child-Protection/pdf/TxFosterCareParameters-September2013.pdf. Accessed October 22, 2013.
27. American Psychiatric Association. Choosing Wisely. Available at: http://www.choosingwisely.org/doctor-patient-lists/american-psychiatric- association/. Accessed October 21, 2013.
28. Institute of Medicine Clinical Practice Guidelines We Can Trust 2011 Institute of Medicine Washington, DC
29. J.C. Andrews, H.J. Schunemann, and A.D. Oxman et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength J Clin Epidemiol 66 2013 726 735
30. National Quality Forum. Review and update of guidance for evaluating evidence and measure testing: draft technical report. NQF Technical Report. October 2, 2013. Available at: http://www.qualityforum.org/Publications/2013/10/ Review-and-Update-of-Guidance-for-Evaluating-Evidence-and-Measure-Testing- Technical-Report.aspx. Accessed February 10, 2014.
31. American Diabetes Association, and American Psychiatric Association American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes J Clin Psychiatry 65 2004 267 272
32. E. Leckman-Westin, E. Kealey, and N. Gupta et al. Validation of a claims-based antipsychotic polypharmacy measure Pharmacoepi Drug Safety 23 2014 628 635
33. G.H. Guyatt, A.D. Oxman, and G.E. Vist et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
34. OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed October 12, 2013.